The global stretch marks treatment market value was US$ 2,496.8 Million in 2021 and is forecast to reach a value of US$ 4,042.55 Million by 2030, growing at a CAGR of 5.5% during the forecast period from 2022 to 2030.
Stretch marks known as scars or wavy lines, result from the epidermis' rapid expansion or contraction. Stretch marks are brought on by unforeseen changes in the body that cause the skin to lose its suppleness and collagen while it heals itself. They are also brought on by Cushing syndrome, Ehlers-Danlos disease, and aberrant collagen synthesis. Pregnant women and those who undergo rapid changes in muscle development due to major weight gain or decrease may acquire stretch marks. Serums, lubricants, fractional lasers, pulse-dye lasers, lotions, and balms are among the treatments for stretch marks that are frequently employed. By closing pores and fine lines, toning the skin, and regenerating collagen, they aid in minimizing the appearance of stretch marks.
Factors Contributing to the Global Market Growth
Impact Analysis of COVID-19
Due to the growing incidence of weight gain among people during the pandemic, which is a major factor in the development of stretch marks, the COVID-19 pandemic had a substantial impact on the market for stretch mark treatments. For instance, according to a January 2022 article in Frontiers in Public Health, weight growth was observed in numerous studies carried out globally during the COVID-19 lockdowns, which prompted a rise in the use of stretch mark treatments to remove stretch marks brought on by obesity. Following the pandemic, the market experienced significant growth, owing to an increase in non-elective hospital admissions (such as stretch mark laser treatment) and healthcare expenditures.
Regional Outlook
Asia Pacific, followed by Europe, is likely to grow at the highest CAGR due to the rising prevalence of obesity, rising birthrate, and worry over stretch marks in the region. According to the European Congress on Obesity's study from May 2022, for example, obesity is more common in Europe than it is in any other region of the world save the Americas. Over 59% of adults, 8% of children under 5, and one in three school-age children in Europe are overweight or obese. The demand for stretch mark treatments in Europe is likely to rise.
Prominent Companies
Some of the top players in the global stretch mark treatment market are:
Segmentation Outline
The global stretch mark treatment market segmentation focuses on Treatment, End-User, and Region.
By Treatment
By End-Users
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL STRETCH MARKS TREATMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL STRETCH MARKS TREATMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL STRETCH MARKS TREATMENT MARKET, BY TREATMENT
5.1 OVERVIEW
5.2 TOPICAL PRODUCT
5.3 LASER
5.4 OTHER TREATMENT
6 GLOBAL STRETCH MARKS TREATMENT MARKET, BY END-USERS
6.1 OVERVIEW
6.2 HOSPITALS AND CLINICS
6.3 HOME USE
7 GLOBAL STRETCH MARKS TREATMENT MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL STRETCH MARKS TREATMENT MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILES
9.1 WELEDA
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.2 UNION SWISS (PTY) LTD.
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.3 LABORATOIRES EXPANSCIENCE
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.4 HRA PHARMA
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.5 HELIX BIOMEDIX INC.
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.6 DERMACLARA
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.7 CANDELA CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.8 CLARINS GROUP
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.9 BASQ SKIN CARE
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.10 ALLIANCE PHARMA PLC
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.11 E. T. BROWNE DRUG CO. INC. (PALMERS)
9.11.1 OVERVIEW
9.11.2 FINANCIAL PERFORMANCE
9.11.3 PRODUCT OUTLOOK
9.11.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved